The product is a novel therapy with the potential to address unmet medical needs in various types of cancer. It utilizes Onk Therapeutics' unique approach to targeting and modulating the immune system to fight cancer, offering a differentiated treatment option for patients, Through this collaboration, Beijing BIOOCUS Biotech Ltd is excited to bring this breakthrough product to the Chinese market, contributing to the advancement of cancer care in the region. With a shared commitment to improving patients' lives, this partnership represents an important step forward in the fight against cancer in China
Please feel free to give your inquiry in the form below We will reply you in 24 hours